Piper Jaffray Initiates Auspex Pharma At Overweight By: Benzinga via Benzinga October 30, 2014 at 08:24 AM EDT Analysts at Piper Jaffray initiated coverage on shares of Auspex Pharma (NASDAQ: ASPX) with a Overweight rating. The target price for ... Read More >>